Vanguard Group’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$641M Sell
34,769,115
-83,444
-0.2% -$1.54M 0.01% 886
2025
Q1
$609M Sell
34,852,559
-138,597
-0.4% -$2.42M 0.01% 885
2024
Q4
$606M Buy
34,991,156
+68,346
+0.2% +$1.18M 0.01% 924
2024
Q3
$650M Buy
34,922,810
+482,191
+1% +$8.97M 0.01% 881
2024
Q2
$530M Sell
34,440,619
-531,992
-2% -$8.19M 0.01% 957
2024
Q1
$517M Buy
34,972,611
+838,654
+2% +$12.4M 0.01% 989
2023
Q4
$487M Sell
34,133,957
-176,802
-0.5% -$2.52M 0.01% 985
2023
Q3
$478M Sell
34,310,759
-31,098
-0.1% -$434K 0.01% 917
2023
Q2
$404M Sell
34,341,857
-1,214,228
-3% -$14.3M 0.01% 1052
2023
Q1
$409M Buy
35,556,085
+120,252
+0.3% +$1.38M 0.01% 1021
2022
Q4
$440M Sell
35,435,833
-93,213
-0.3% -$1.16M 0.01% 954
2022
Q3
$466M Sell
35,529,046
-361,147
-1% -$4.74M 0.01% 879
2022
Q2
$501M Sell
35,890,193
-427,096
-1% -$5.97M 0.01% 858
2022
Q1
$541M Buy
36,317,289
+859,548
+2% +$12.8M 0.01% 911
2021
Q4
$480M Buy
35,457,741
+1,200,707
+4% +$16.3M 0.01% 1023
2021
Q3
$504M Buy
34,257,034
+388,742
+1% +$5.72M 0.01% 970
2021
Q2
$616M Buy
33,868,292
+1,003,809
+3% +$18.3M 0.02% 860
2021
Q1
$571M Buy
32,864,483
+494,439
+2% +$8.58M 0.02% 878
2020
Q4
$562M Buy
32,370,044
+485,276
+2% +$8.43M 0.02% 822
2020
Q3
$440M Sell
31,884,768
-1,162,198
-4% -$16M 0.01% 834
2020
Q2
$477M Buy
33,046,966
+648,716
+2% +$9.36M 0.02% 786
2020
Q1
$354M Buy
32,398,250
+1,336,678
+4% +$14.6M 0.02% 827
2019
Q4
$663M Buy
31,061,572
+1,673,924
+6% +$35.7M 0.02% 684
2019
Q3
$675M Buy
29,387,648
+1,451,948
+5% +$33.3M 0.03% 657
2019
Q2
$550M Buy
27,935,700
+440,936
+2% +$8.68M 0.02% 752
2019
Q1
$535M Buy
27,494,764
+182,856
+0.7% +$3.56M 0.02% 749
2018
Q4
$450M Buy
27,311,908
+1,149,082
+4% +$18.9M 0.02% 755
2018
Q3
$605M Buy
26,162,826
+173,363
+0.7% +$4.01M 0.02% 700
2018
Q2
$565M Sell
25,989,463
-1,188,113
-4% -$25.8M 0.02% 709
2018
Q1
$480M Sell
27,177,576
-3,636,112
-12% -$64.2M 0.02% 773
2017
Q4
$578M Buy
30,813,688
+359,139
+1% +$6.74M 0.03% 692
2017
Q3
$668M Buy
30,454,549
+17,224,990
+130% +$378M 0.03% 601
2017
Q2
$319M Buy
13,229,559
+797,491
+6% +$19.2M 0.02% 943
2017
Q1
$347M Buy
12,432,068
+734,489
+6% +$20.5M 0.02% 856
2016
Q4
$286M Buy
11,697,579
+917,510
+9% +$22.4M 0.02% 939
2016
Q3
$271M Buy
10,780,069
+528,214
+5% +$13.3M 0.02% 903
2016
Q2
$212M Buy
10,251,855
+302,868
+3% +$6.25M 0.01% 1023
2016
Q1
$200M Buy
9,948,987
+393,778
+4% +$7.91M 0.01% 1035
2015
Q4
$193M Buy
9,555,209
+217,065
+2% +$4.39M 0.01% 1032
2015
Q3
$216M Buy
9,338,144
+98,499
+1% +$2.28M 0.02% 953
2015
Q2
$238M Buy
9,239,645
+1,036,254
+13% +$26.7M 0.02% 950
2015
Q1
$272M Buy
8,203,391
+579,782
+8% +$19.2M 0.02% 868
2014
Q4
$232M Buy
7,623,609
+266,415
+4% +$8.09M 0.02% 885
2014
Q3
$179M Buy
7,357,194
+816,708
+12% +$19.9M 0.01% 1000
2014
Q2
$188M Buy
6,540,486
+1,196,874
+22% +$34.4M 0.01% 1001
2014
Q1
$149M Buy
5,343,612
+282,288
+6% +$7.87M 0.01% 1095
2013
Q4
$132M Buy
5,061,324
+179,990
+4% +$4.7M 0.01% 1138
2013
Q3
$112M Buy
4,881,334
+81,223
+2% +$1.87M 0.01% 1163
2013
Q2
$125M Buy
+4,800,111
New +$125M 0.01% 1022